We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Survey · December 27, 2019

PCSK9 Inhibitor Use

 

Please complete the survey below. Your response will be tabulated and published anonymously to help inform other healthcare professionals.

Which best describes your use of PCSK9 inhibitors for lipid managment?

Please sign in to complete this survey.

Additional Surveys

Further Reading